PDT Partners, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$253,000
+29.7%
16,451
-6.7%
0.02%
+30.8%
Q3 2020$195,000
-47.6%
17,633
-40.6%
0.01%
-48.0%
Q2 2020$372,000
+48.8%
29,679
+34.4%
0.02%
+25.0%
Q1 2020$250,000
+17.9%
22,089
+37.4%
0.02%
+122.2%
Q3 2018$212,000
+29.3%
16,074
-9.9%
0.01%
+50.0%
Q2 2018$164,00017,8370.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders